ALS drug may help treat prostate cancer

prostate cancer
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

Researchers have discovered a new use for an old drug as a potential treatment for prostate cancer. The findings are published in the journal The Prostate.

Since the 1940s, androgens have been linked to , and decades of work since have focused on (AR), a nuclear receptor transcription factor. Although AR drives prostate cancer, inhibiting it induces remission for only a short time. Investigators have found that a drug approved for the treatment of amyotrophic lateral sclerosis—called riluzole—promotes the degradation of AR through a distinct pathway.

The findings suggest that riluzole should be investigated clinically for prostate cancer and predict that it may be effective for both and advanced disease," said senior author Dr. Shahriar Koochekpour, of Roswell Park Comprehensive Cancer Center.


Explore further

A new method for prostate cancer imaging

More information: Kristine M. Wadosky et al, Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells, The Prostate (2018). DOI: 10.1002/pros.23719
Provided by Wiley
Citation: ALS drug may help treat prostate cancer (2018, October 3) retrieved 19 July 2019 from https://medicalxpress.com/news/2018-10-als-drug-prostate-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more